CDN$550,000 Advance on Biotech Firm’s Path to Becoming Publicly Traded Company SCOTTSDALE, AZ–(Marketwired – October 16, 2015) – Lattice Biologics Inc. is pleased to announce that Blackstone Ventures Inc. (TSX VENTURE: BLV), a company listed on the TSX Venture Exchange, has received funding of CDN$1.37